Quarterly Statement Of Cash Flows

Mochida Pharmaceutical Co.,Ltd. - Filing #7537456

Concept As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-5,517,000,000 JPY
6,821,000,000 JPY
Interest and dividends received
182,000,000 JPY
172,000,000 JPY
Income taxes paid
-587,000,000 JPY
-1,854,000,000 JPY
Net cash provided by (used in) operating activities
-5,930,000,000 JPY
5,174,000,000 JPY
Cash flows from investing activities
Purchase of securities
-4,500,000,000 JPY
-4,500,000,000 JPY
Proceeds from sale of securities
4,500,000,000 JPY
4,500,000,000 JPY
Purchase of investment securities
-300,000,000 JPY
JPY
Proceeds from sale of investment securities
15,000,000 JPY
JPY
Other, net
14,000,000 JPY
-25,000,000 JPY
Net cash provided by (used in) investing activities
-1,790,000,000 JPY
-2,139,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-2,930,000,000 JPY
-937,000,000 JPY
Dividends paid
-1,462,000,000 JPY
-1,879,000,000 JPY
Other, net
-6,000,000 JPY
0 JPY
Net cash provided by (used in) financing activities
-4,399,000,000 JPY
-2,816,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
67,000,000 JPY
70,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-12,053,000,000 JPY
289,000,000 JPY
Cash and cash equivalents
25,957,000,000 JPY
38,010,000,000 JPY
40,804,000,000 JPY
40,515,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.